Rheumatology

Latest News

FDA Approves Bimekizumab-Bkzx for Psoriatic Arthritis, 2 Other Indications
FDA Approves Bimekizumab-Bkzx for Psoriatic Arthritis, 2 Other Indications

September 23rd 2024

The monoclonal antibody was also approved for active non-radiographic axial spondyloarthritis and active ankylosing spondylitis.

Latest CME Events & Activities
© 2024 MJH Life Sciences

All rights reserved.